Repare Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Repare Therapeutics Inc., , a leading clinical-stage precision oncology company, today announced that, in connection with the appointment of Daniel Belanger as the Company’s EVP, Human... | May 22, 2023

Related Keywords

Daniel Belanger ,Repare Therapeutics Inc ,Nasdaq ,Human Resources ,Compensation Committee ,Incentive Plan ,Nasdaq Listing Rule ,Repare Therapeutics ,Repare Therapeutics Inc Stock Exchange ,News ,Information ,Press Release ,Prepare ,Herapeutics ,Reading ,Precision ,Ncology ,Oday ,Nnounced ,N ,Connection ,Ith ,The ,Appointment ,F ,Daniel ,Selanger ,Us ,He Rptx Us7602731025 ,